Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Topical Infliximab Versus Topical Steroid in Autoimmune Dry Eye Disease: Randomized Controlled Trial.

NCT07671222 is registered in ClinicalTrials.gov with Instituto de Oftalmología Fundación Conde de Valenciana as lead sponsor.

NCT NCT07671222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07671222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Topical Infliximab Versus Topical Steroid in Autoimmune Dry Eye Disease: Randomized Controlled Trial.
Lead sponsor
Instituto de Oftalmología Fundación Conde de Valenciana
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
March 31, 2028
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease (ded), sjogren syndrome, sjogren syndrome with keratoconjunctivitis